查看完整行情页>>

|

货币单位:美元(USD)

赛诺菲-安万特

Sanofi (sny)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Paul Hudson Paul Hudson is a businessperson who has been the head of 6 different companies. Currently, Mr. Hudson occupies the position of Chief Executive Officer & Director at Sanofi and Chairman for Novartis Pharma KK. He previously occupied the position of President-AstraZeneca US & EVP-North America at AstraZeneca PLC President & Director at AstraZeneca KK and President of AstraZéneca Farmacéutica Spain SA (both are subsidiaries of AstraZeneca PLC), Member-Executive Committee at Novartis AG and Chief Executive Officer at Novartis Pharmaceuticals Corp. (a subsidiary of Novartis AG), Chief Executive Officer & Director at Sanofi Clir SNC and Head-Global Marketing at Schering Plough Holdings France SAS. Mr. Hudson received an undergraduate degree from Manchester Metropolitan University.
Serge Weinberg Founder of Weinberg Capital Partners SAS and Institut du Cerveau et de la Moelle Épinière, Serge Weinberg is a French businessperson who has been at the head of 19 different companies and presently holds the position of CEO at Weinberg Capital Partners SAS. Mr. Weinberg is also on the board of Sanofi (former Chairman), Kering SA, Piasa SA (former Chairman) and AFEPT and Member of Council on Foreign Relations, Inc., Manager at Maremma and Manager of Alret. He previously occupied the position of Chairman & Chief Executive Officer at Rexel SA, Chairman for Accor SA, Director at VL Holding (France), Chairman for Financière Piasa SAS, Chairman of Piasa Holding SAS, Chairman-Supervisory Board at Financière Climater SAS, Chairman of Maremma SASU, Chairman-Supervisory Board for Financière Tess SAS, Chairman for CORUM Vermögensverwaltung AG, Chairman-Supervisory Board for Tess SAS, Chief Executive Officer & Director at Pallas Finance, Chairman-Management Board at Kering SA, President-CFAO at Pinault SARL, Manager of Adoval, Chairman & Chief Executive Officer of Havas Tourisme, Chairman at Montres Corum SARL, President for Compagnie Française de L'Afrique Occidentale SA and Deputy General Manager-Finance at France 3 SA. Serge Weinberg received a graduate degree from Institut d'Études Politiques d'Aix-en-Provence and an undergraduate degree from Ecole Nationale d'Administration.
Frédéric Oudéa Frédéric Oudéa is a French businessperson who has been at the helm of 6 different companies and presently occupies the position of Independent Chairman for Sanofi, Chairman for Fondation Ecole Polytechnique and Chief Executive Officer of Société Générale SA (Broker). He is also President at Fédération Bancaire Française and on the board of 6 other companies. In the past Mr. Oudéa held the position of Chief Executive Officer & Director at Société Générale SA and President at European Banking Federation aisbl. He received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from Ecole Nationale d'Administration.
Jean-Baptiste Chasseloup de Chatillon Jean-Baptiste Chasseloup de Chatillon is a French businessperson who has been at the head of 5 different companies. Currently, he is Chief Financial Officer & Executive Vice President at Sanofi. He is also Chief Financial & Information Officer at Fondation PSA Peugeot Citroën, Associate Manager at Peugeot Media Production SNC and Member of City on the Move Institute and on the board of 9 other companies. In the past Mr. Chasseloup de Chatillon held the position of Chairman at Asm Auto Sud Marche SAS, Chairman for Banque PSA Finance SA, Chairman-Supervisory Board for Peugeot Finance International NV, Chairman for Mister Auto SAS, Vice Chairman & Chief Executive Officer at Stellantis International SA, Chief Financial Officer & EVP-Information Systems at Peugeot SA, Imports Director-Europe at Automobiles Citroën SA and Managing Director at Citroën Belux SA. He received an undergraduate degree from Université Paris Dauphine-PSL and an undergraduate degree from the University of Lancaster.
Natalie Bickford Currently, Natalie Bickford holds the position of Chairman of Women 1st Ltd. and Chief People Officer & Executive Vice President at Sanofi. She is also on the board of Bryanston School, Inc. and Director-Kronos Workforce Institute at Kronos, Inc. In her past career she held the position of Manager at Barclays PLC, Director-Group Human Resources at Merlin Entertainments Plc, Director-Human Resources of Sodexho Ltd. and Member-Women's Leadership Group at The Prince's Trust. Natalie Bickford received an undergraduate degree from the University of Warwick.
Houman Ashrafian Houman Ashrafian is an entrepreneur and businessperson who founded 10 companies, including: Heart Metabolics Ltd., Dualitas Ltd. and Sitryx Therapeutics Ltd. and who has been the head of 5 different companies. Currently, Dr. Ashrafian occupies the position of Chairman for Weatherden Ltd. (which he founded), Executive VP, Head-Research & Development at Sanofi and Scientific Advisor at SV Health Investors LLP, Managing Partner at SV Health Managers LLP (a subsidiary of SV Health Investors LLP). He is also on the board of Ervaxx Ltd., Zarodex Therapeutics Ltd., Cellinta Ltd. and Cybele Therapeutics Ltd. He previously held the position of Director at Therini Bio, Inc., Chairman at Alchemab Therapeutics Ltd. (he founded the company), Director at Mestag Therapeutics Ltd. (he founded the company), Chairman for Enara Bio Ltd. (he founded the company), Director at Sitryx Therapeutics Ltd. and Director at TRex Bio Ltd. Dr. Ashrafian received an undergraduate degree and a doctorate from the University of Oxford and a graduate degree and an undergraduate degree from the University of Cambridge.
Nestle Frank Presently, Nestle Frank is Chief Scientific Officer & Global Head-Research at Sanofi.
Madeleine Roach Madeleine Roach is Executive Vice President-Business Operations at Sanofi. In her past career she was Head-Global Finance Services Asia Pacific at AstraZeneca GmbH. Ms. Roach received an undergraduate degree from the University of London.
Preethi Sundaram Presently, Preethi Sundaram is Director-Global Clinical Research at Sanofi. She is also Chief Strategy Officer at Catalyst Pharmaceuticals, Inc. Dr. Sundaram received a doctorate from the University of Anglia Ruskin, an undergraduate degree from the University of Madras, an MBA from London Business School and an undergraduate degree from Birla Institute of Technology & Science.
Emmanuel Frenehard Emmanuel Frenehard is Chief Digital Officer & Executive Vice President at Sanofi. He received an undergraduate degree from EBS Universität für Wirtschaft und Recht gGmbH and a graduate degree from Institut Supérieur de Gestion.
Raj Verma Raj Verma is Chief Diversity, Culture & Experience Officer at Sanofi.
Dietmar P. Berger Currently, Dietmar P. Berger holds the position of Chief Medical Officer & Global Head-Development at Sanofi. In his past career Dr. Berger occupied the position of Global Head-Research & Development at Atara Biotherapeutics, Inc., Head-Clinical Research Centre at Universitätsklinikum Freiburg, Vice President-Clinical Hematology & Oncology at Genentech, Inc. and Head-Clinical Research Centre at The Scripps Research Institute. He received a graduate degree and a doctorate from the University of Freiburg.
Lise Kingo Lise Kingo is Chairman-Leonardo Centre at Imperial College London and Member of Prince of Wales and on the board of 5 other companies. In the past Ms. Kingo occupied the position of Chairman for Steno Diabetes Center A, Chairman for Danish Council On Corporate Social Responsibility, Chief of Staff & Executive Vice President at Novo Nordisk A, Director-Corporate Environmental Affairs at Novozymes A, Senior Vice President-Stakeholder Relations at Novo Holdings AS (Denmark), Chief Executive Officer & Executive Director at United Nations Global Compact and Professor at Vrije Universiteit Amsterdam. She received an undergraduate degree from the University of Aarhus, an undergraduate degree from Copenhagen Business School and a graduate degree from the University of Bath.
Emile Voest Founder of Hubrecht Organoid Technology Foundation, Hartwig Medical Foundation and Center For Personalized Cancer Therapy, Emile Voest is an entrepreneur is on the board of Sanofi, Hartwig Medical Foundation and Center For Personalized Cancer Therapy and Professor at the University of Utrecht. In his past career Dr. Voest was Medical Director for Hubrecht Organoid Technology Foundation and Executive Medical Director at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh. Dr. Voest received a doctorate from the University of Utrecht.
Emmanuel Andre Marie Babeau Currently, Emmanuel Andre Marie Babeau is Chief Financial Officer at Philip Morris International, Inc. Mr. Babeau is also Managing Partner at Sci Getij and on the board of 8 other companies. In the past Mr. Babeau was Deputy Chief Executive Officer at Pernod Ricard SA and Deputy Chief Executive Officer-Finance & Legal at Schneider Electric SE Chairman & Member-Management Board at Schneider Electric Services International SPRL, Chief Financial Officer for Schneider Electric Ltd. and Member-Management Board at Schneider SA (which are all subsidiaries of Schneider Electric SE). Mr. Babeau received an undergraduate degree from ESCP Europe Campus Paris.
Gilles Schnepp Mr. Schnepp is the former chairman and CEO of Legrand SA. Under his leadership from 2006 through 2018, Legrand grew revenue from approximately 3.7 billion euro to 6 billion euro and net profit from 255 million euro to 772 million euro. During this period, Mr. Schnepp broadened Legrand’s product offering from primarily European markets to a global portfolio of electrical and digital infrastructure solutions, drove Legrand’s expansion into the US as well as into emerging markets, including China, Brazil, and India, as well as an acquisition strategy which added approximately $2 billion in revenue. He serves as a director of Saint-Gobain and Sanofi and is a member of the supervisory board of PSA. Mr. Schnepp began his career at Merrill Lynch before serving as Legrand’s deputy chief financial officer and later chief financial officer. He was twice awarded “Manager of the Year” by Challenges magazine and thrice among the “Best 100 CEOs” by Harvard Business Review. Mr. Schnepp is a member of the executive committee of the employer association MEDEF, chairman of the French Federation of Electrical, Electronic and Communication Industries (FIEEC), chairman of the ESG Commission, a recipient of The Order of Légion d’Honneur, and was awarded the National Order of Merit in 2012. Mr. Schnepp attended the HEC Paris.
Patrick Kron Patrick Kron is a French businessperson who founded Pkc&I SAS and who has been the head of 14 different companies. He is Chairman at this company, Chairman for Imerys SA and Independent Chairman for Imerys SA. He is also on the board of Sanofi, Viohalco SA and Gentilly Verdun SNC. In his past career Patrick Kron was Chairman & Chief Executive Officer for Alstom SA Chairman & Chief Executive Officer of ALSTOM Transport SA, Chairman for ALSTOM Resources Management SAS, Chief Executive Officer & Director at GE Power Solutions (Malaysia) Sdn. Bhd. and Managing Director & Director at Alstom Asia Pte Ltd. (which are all subsidiaries of Alstom SA), Chairman for Mersen SA and Chairman & Chief Executive Officer of Mersen France Amiens SAS (a subsidiary of Mersen SA), Chief Executive Officer for Vivendi SE, Chairman & Chief Executive Officer at FERROPEM SASU, Chairman for Imerys Talc Canada, Inc., Chief Executive Officer at Imerys SA, Chief Operating Officer of American National Can Corp, Manager-Food & Health Care Packaging Sector at Pechiney SA and Vice Chairman at Les Arts Florissants. Mr. Kron received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris.
Diane D. Souza Diane D. Souza is on the board of Amica Mutual Insurance Co., Sanofi and DBP Services of New York IPA, Inc. Ms. Souza previously occupied the position of Chief Executive Officer-Specialty Benefits at UnitedHealth Group, Inc. Chief Executive Officer at UnitedHealthcare Specialty Benefits LLC and COO-OptumHealth Specialty Benefits at OptumHealth, Inc. (both are subsidiaries of UnitedHealth Group, Inc.), Principal at Deloitte, Haskins & Sells (France), CFO-Guaranteed Products Business at Aetna, Inc. and Accountant at Pricewaterhouse LLP. Diane D. Souza received an undergraduate degree from the University of Massachusetts.
Claudie Haigneré Claudie Haigneré is Member of Academie de l'air et de l'espace, Member of Académie des Sciences et Technologies, Member of Académie Des Sciences D'Outre-Mer and Member of Academie des Sports and on the board of 6 other companies. In her past career she held the position of Chairman for Universcience.fr, Chairman at La Géode, Counselor at European Space Agency (France), Member of International Academy of Astronautics and Member of Académie des Technologies.
Rachel Duan Rachel Duan is on the board of AXA SA, Adecco Group AG, HSBC Holdings Plc and Sanofi. In the past Ms. Duan was Senior VP, President & CEO-Global Markets at General Electric Co. Chief Executive Officer of GE (China) Co., Ltd. and Commercial Director at GE Plastics China Ltd. (both are subsidiaries of General Electric Co.) and Chief Executive Officer of GE Healthcare (China) Co. Ltd. Rachel Duan received an MBA from the University of Wisconsin and an undergraduate degree from Shanghai International Studies University.
Fabienne Lecorvaisier Presently, Fabienne Lecorvaisier is Chairman for Air Liquide USA LLC. Ms. Lecorvaisier is also Executive Vice President for Air Liquide International Corp. and on the board of 6 other companies. She previously occupied the position of Executive Vice President at Air Liquide SA Chairman & Chief Executive Officer at Air Liquide Finance SA, Chairman for Air Liquide USA LLC and Vice President-Operations & Finance at Air Liquide Italia SpA (which are all subsidiaries of Air Liquide SA), Member-Corporate Finance Department at Société Générale SA, Assistant General Manager at Taittinger SAS, Officer at Legion of Honor, Chief Strategy & Acquisitions Officer at Essilor Group Canada Ltd., Assistant General Manager at Banque du Louvre and Director-Finance & Information Systems at Essilor of America, Inc. She received an undergraduate degree from Ecole Nationale des Ponts et Chaussées.
Barbara Lavernos Barbara Lavernos holds the position of Deputy CEO-Research, Innovation & Technology at L'Oréal SA and Chief Technology, Operations Officer & EVP at L'Oréal Canada, Inc. (a subsidiary of L'Oréal SA). She is also on the board of Sanofi and Lactobio A. Barbara Lavernos received an undergraduate degree from École des Hautes Études d’Ingénieur.
Carole Gabriella Ferrand Presently, Carole Gabriella Ferrand is Chief Financial Officer at Capgemini Group, Chairman of Isai Cap Venture and Chief Finance Officer & General Secretary at Sony France SA. She is also on the board of 8 other companies. In the past she was Chief Financial Officer for Capgemini SE and Chief Financial Officer for Capgemini Technology Services India Ltd. (a subsidiary of Capgemini SE), Financing Director at Financière Pinault SCA, Chief Financial Officer at EuropaCorp SA, Chief Financial Officer & General Counsel at Sony Semiconductor Manufacturing Corp. (Japan) and Auditor for PricewaterhouseCoopers France SARL. She received an undergraduate degree from École des Hautes Études Commerciales de Paris.
Antoine Yver Presently, Antoine Yver occupies the position of Executive Vice President & Chairman-Development at Centessa Pharmaceuticals Plc. He is also on the board of Sanofi and Spotlight Therapeutics, Inc. In the past Dr. Yver was Head-Global Medicines Development at AstraZeneca PLC, EVP, Global Head-Oncology Research and Development at Daiichi Sankyo Co., Ltd., Senior Director at Aventis SA, Executive Director at Schering-Plough SAS and Senior Director at Johnson & Johnson Medical SAS. He received an undergraduate degree and a doctorate from Université Paris-Saclay.
Thomas C. Südhof Founder of Reata Pharmaceuticals, Inc., Circuit Therapeutics, Inc., Neucyte, Inc. and Recognify Life Sciences, Inc., Thomas C. Südhof is an entrepreneur who currently is Venture Partner at Catalio Capital Management LP, Scientific Advisory Board at Simcere Pharmaceutical Group Ltd., Scientific Advisory Board at Elysium Pharmaceuticals Ltd., Scientific Advisory Board at Alector, Inc. and Scientific Advisory Board at Jupiter Therapeutics, Inc. He is also on the board of Sanofi and CytoDel LLC and Member of The Royal Society, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Deutsche Akademie der Naturforscher Leopoldina eV, Professor at Stanford University School of Medicine and Member of The Royal Norwegian Society For Development. Dr. Südhof previously held the position of Member-Neuroscience Review Board at Genentech, Inc., Assistant Professor at The University of Texas Southwestern Medical Center and Research Assistant at Max Planck Institute For Biophysical Chemistry. Dr. Südhof received a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen.